Siglec-8 hFc Chimera, Human
Siglec-8 HFc Chimera, Human

The purity of Siglec-8 hFc Chimera, Human is greater than 95% as determined by SEC-HPLC.

Siglec-8 HFc Chimera, Human

Siglec-8 hFc Chimera, Human on Bis-Tris PAGE under reduced conditions. The purity is greater than 95%.

Siglec-8 hFc Chimera, Human

Siglec-8, also known as SAF, is an approximately 75 kDa transmembrane glycoprotein in the Siglec family of sialic acid-binding immune regulatory molecules. Mature human Siglec-8 consists of a 347 amino acid (aa) extracellular domain (ECD) with three Ig-like domains.Putative adhesion molecule that mediates sialic-acid dependent binding to red blood cells. Preferentially binds to alpha-2,3-linked sialic acid. Also binds to alpha-2,6-linked sialic acid.
Z05827
¥72,752.00

Ask us a question
Product Introduction
Species Human
Protein Construction
Siglec-8 (Met17-Ala363)_x000D_
Accession # Q9NYZ4		 hFc
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
> 95% as determined by HPLC
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 64.6 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 70-82 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Examples
  • Siglec-8 HFc Chimera, Human
    • Siglec-8 HFc Chimera, Human

    The purity of Siglec-8 hFc Chimera, Human is greater than 95% as determined by SEC-HPLC.

  • Siglec-8 HFc Chimera, Human
    • Siglec-8 HFc Chimera, Human

    Siglec-8 hFc Chimera, Human on Bis-Tris PAGE under reduced conditions. The purity is greater than 95%.


Background
Target Background Siglec-8, also known as SAF, is an approximately 75 kDa transmembrane glycoprotein in the Siglec family of sialic acid-binding immune regulatory molecules. Mature human Siglec-8 consists of a 347 amino acid (aa) extracellular domain (ECD) with three Ig-like domains.Putative adhesion molecule that mediates sialic-acid dependent binding to red blood cells. Preferentially binds to alpha-2,3-linked sialic acid. Also binds to alpha-2,6-linked sialic acid.
Synonyms CDw329; MGC59785; SAF2; SAF2SAF-2; Siglec-8; SIGLEC8L; SIGLEC8

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.